nodes	percent_of_prediction	percent_of_DWPC	metapath
Bopindolol—ADRB2—prostate cancer	0.874	1	CbGaD
Bopindolol—Carvedilol—GJA1—prostate cancer	0.00276	0.202	CrCbGaD
Bopindolol—Carvedilol—HIF1A—prostate cancer	0.00209	0.153	CrCbGaD
Bopindolol—Carteolol—ADRB2—prostate cancer	0.00118	0.0861	CrCbGaD
Bopindolol—Bupranolol—ADRB2—prostate cancer	0.001	0.0733	CrCbGaD
Bopindolol—Carvedilol—VEGFA—prostate cancer	0.000843	0.0615	CrCbGaD
Bopindolol—Mebendazole—CYP1A1—prostate cancer	0.000825	0.0602	CrCbGaD
Bopindolol—Ketoprofen—CXCL8—prostate cancer	0.000764	0.0558	CrCbGaD
Bopindolol—Mebendazole—CYP3A4—prostate cancer	0.000526	0.0384	CrCbGaD
Bopindolol—Carvedilol—ADRB2—prostate cancer	0.000474	0.0346	CrCbGaD
Bopindolol—Propranolol—CYP3A5—prostate cancer	0.000456	0.0333	CrCbGaD
Bopindolol—Carvedilol—CYP2E1—prostate cancer	0.000412	0.0301	CrCbGaD
Bopindolol—Carvedilol—CYP1A1—prostate cancer	0.000407	0.0297	CrCbGaD
Bopindolol—Propranolol—ADRB2—prostate cancer	0.000361	0.0263	CrCbGaD
Bopindolol—Propranolol—CYP2C19—prostate cancer	0.000311	0.0227	CrCbGaD
Bopindolol—Propranolol—CYP1A1—prostate cancer	0.000309	0.0226	CrCbGaD
Bopindolol—Propafenone—CYP3A4—prostate cancer	0.000288	0.0211	CrCbGaD
Bopindolol—Carvedilol—CYP3A4—prostate cancer	0.00026	0.019	CrCbGaD
Bopindolol—Ketoprofen—PTGS2—prostate cancer	0.000223	0.0163	CrCbGaD
Bopindolol—Propranolol—CYP3A4—prostate cancer	0.000198	0.0144	CrCbGaD
Bopindolol—HTR1B—Signaling Pathways—BAD—prostate cancer	1.94e-05	0.000173	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—LPL—prostate cancer	1.93e-05	0.000172	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PIK3CB—prostate cancer	1.93e-05	0.000172	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—IL2—prostate cancer	1.92e-05	0.000171	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PDGFRB—prostate cancer	1.92e-05	0.000171	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ITGB3—prostate cancer	1.91e-05	0.00017	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—PIK3CB—prostate cancer	1.9e-05	0.000169	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—LPL—prostate cancer	1.89e-05	0.000168	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—APC—prostate cancer	1.88e-05	0.000167	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PIK3CG—prostate cancer	1.88e-05	0.000167	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—IL2—prostate cancer	1.88e-05	0.000167	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PDGFRB—prostate cancer	1.87e-05	0.000167	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ITGB3—prostate cancer	1.87e-05	0.000166	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—CXCL8—prostate cancer	1.86e-05	0.000166	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—EGF—prostate cancer	1.86e-05	0.000165	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IRS1—prostate cancer	1.86e-05	0.000165	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—PIK3CB—prostate cancer	1.86e-05	0.000165	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CXCL8—prostate cancer	1.86e-05	0.000165	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ERBB3—prostate cancer	1.85e-05	0.000165	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—FGFR2—prostate cancer	1.85e-05	0.000165	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ITGB3—prostate cancer	1.83e-05	0.000163	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—CXCL8—prostate cancer	1.82e-05	0.000162	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CDKN1B—prostate cancer	1.81e-05	0.000161	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ERBB3—prostate cancer	1.81e-05	0.000161	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—FGFR2—prostate cancer	1.81e-05	0.000161	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—GSK3B—prostate cancer	1.8e-05	0.00016	CbGpPWpGaD
Bopindolol—ADRB3—GPCR downstream signaling—AKT1—prostate cancer	1.79e-05	0.00016	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—CXCL8—prostate cancer	1.78e-05	0.000159	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—IL2—prostate cancer	1.78e-05	0.000159	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—INS—prostate cancer	1.78e-05	0.000158	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CASP3—prostate cancer	1.78e-05	0.000158	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TERT—prostate cancer	1.77e-05	0.000158	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL2—prostate cancer	1.77e-05	0.000158	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ERBB3—prostate cancer	1.77e-05	0.000158	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—FGFR2—prostate cancer	1.77e-05	0.000157	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—IL6—prostate cancer	1.76e-05	0.000157	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL2—prostate cancer	1.74e-05	0.000155	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CREBBP—prostate cancer	1.74e-05	0.000155	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TERT—prostate cancer	1.74e-05	0.000155	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CCND1—prostate cancer	1.73e-05	0.000154	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IGF1—prostate cancer	1.72e-05	0.000153	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CTNNB1—prostate cancer	1.71e-05	0.000152	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—EGFR—prostate cancer	1.71e-05	0.000152	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL2—prostate cancer	1.7e-05	0.000152	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TERT—prostate cancer	1.7e-05	0.000151	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—HIF1A—prostate cancer	1.7e-05	0.000151	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MMP9—prostate cancer	1.68e-05	0.000149	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—CDKN1A—prostate cancer	1.67e-05	0.000149	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PTEN—prostate cancer	1.67e-05	0.000149	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MAP2K1—prostate cancer	1.66e-05	0.000148	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—HIF1A—prostate cancer	1.66e-05	0.000148	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—LEP—prostate cancer	1.66e-05	0.000148	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PIK3CD—prostate cancer	1.65e-05	0.000147	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CAV1—prostate cancer	1.64e-05	0.000146	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—PIK3CA—prostate cancer	1.63e-05	0.000146	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—SERPINE1—prostate cancer	1.63e-05	0.000145	CbGpPWpGaD
Bopindolol—ADRB3—Signaling by GPCR—AKT1—prostate cancer	1.63e-05	0.000145	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—HIF1A—prostate cancer	1.62e-05	0.000145	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—KDR—prostate cancer	1.62e-05	0.000145	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—LEP—prostate cancer	1.62e-05	0.000144	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—KRAS—prostate cancer	1.62e-05	0.000144	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CAV1—prostate cancer	1.61e-05	0.000143	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—EP300—prostate cancer	1.59e-05	0.000142	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—KDR—prostate cancer	1.59e-05	0.000141	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—LEP—prostate cancer	1.58e-05	0.000141	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ESR1—prostate cancer	1.58e-05	0.000141	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—FGF2—prostate cancer	1.58e-05	0.000141	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CAV1—prostate cancer	1.57e-05	0.00014	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—NOS3—prostate cancer	1.56e-05	0.000139	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—KDR—prostate cancer	1.55e-05	0.000138	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ESR1—prostate cancer	1.55e-05	0.000138	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—SRC—prostate cancer	1.55e-05	0.000138	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—BAD—prostate cancer	1.54e-05	0.000137	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—JAK2—prostate cancer	1.51e-05	0.000135	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ESR1—prostate cancer	1.51e-05	0.000135	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—BAD—prostate cancer	1.51e-05	0.000134	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—VEGFA—prostate cancer	1.51e-05	0.000134	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—APC—prostate cancer	1.5e-05	0.000133	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PIK3CG—prostate cancer	1.5e-05	0.000133	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—STAT3—prostate cancer	1.49e-05	0.000133	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—PIK3CA—prostate cancer	1.48e-05	0.000132	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MDM2—prostate cancer	1.48e-05	0.000132	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EGF—prostate cancer	1.48e-05	0.000132	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IRS1—prostate cancer	1.48e-05	0.000132	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—BAD—prostate cancer	1.48e-05	0.000131	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—APC—prostate cancer	1.46e-05	0.00013	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PIK3CG—prostate cancer	1.46e-05	0.00013	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—ERBB2—prostate cancer	1.46e-05	0.00013	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IRS1—prostate cancer	1.45e-05	0.000129	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EGF—prostate cancer	1.45e-05	0.000129	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PIK3CB—prostate cancer	1.44e-05	0.000128	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—GSK3B—prostate cancer	1.43e-05	0.000128	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—APC—prostate cancer	1.43e-05	0.000127	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PIK3CG—prostate cancer	1.43e-05	0.000127	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—INS—prostate cancer	1.42e-05	0.000126	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EGF—prostate cancer	1.41e-05	0.000126	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IRS1—prostate cancer	1.41e-05	0.000126	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—GSK3B—prostate cancer	1.4e-05	0.000125	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CREBBP—prostate cancer	1.39e-05	0.000123	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—MYC—prostate cancer	1.39e-05	0.000123	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—INS—prostate cancer	1.38e-05	0.000123	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—TGFB1—prostate cancer	1.38e-05	0.000123	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CXCL8—prostate cancer	1.38e-05	0.000123	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—GSK3B—prostate cancer	1.37e-05	0.000122	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IGF1—prostate cancer	1.37e-05	0.000122	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—EGFR—prostate cancer	1.36e-05	0.000121	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CREBBP—prostate cancer	1.36e-05	0.000121	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—EGFR—prostate cancer	1.36e-05	0.000121	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—INS—prostate cancer	1.35e-05	0.000121	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CDKN1B—prostate cancer	1.35e-05	0.00012	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IGF1—prostate cancer	1.34e-05	0.000119	CbGpPWpGaD
Bopindolol—HTR1B—GPCR downstream signaling—AKT1—prostate cancer	1.34e-05	0.000119	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—EGFR—prostate cancer	1.33e-05	0.000119	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CREBBP—prostate cancer	1.33e-05	0.000118	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CASP3—prostate cancer	1.32e-05	0.000118	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MAP2K1—prostate cancer	1.32e-05	0.000118	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL2—prostate cancer	1.32e-05	0.000118	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—IL6—prostate cancer	1.31e-05	0.000117	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PIK3CD—prostate cancer	1.31e-05	0.000117	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IGF1—prostate cancer	1.31e-05	0.000117	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—EGFR—prostate cancer	1.3e-05	0.000116	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—PIK3CA—prostate cancer	1.3e-05	0.000116	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SERPINE1—prostate cancer	1.3e-05	0.000116	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MAP2K1—prostate cancer	1.29e-05	0.000115	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CCND1—prostate cancer	1.29e-05	0.000115	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—KRAS—prostate cancer	1.29e-05	0.000115	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PIK3CD—prostate cancer	1.29e-05	0.000114	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—KRAS—prostate cancer	1.28e-05	0.000114	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CTNNB1—prostate cancer	1.28e-05	0.000114	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—PIK3CA—prostate cancer	1.27e-05	0.000113	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SERPINE1—prostate cancer	1.27e-05	0.000113	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MAP2K1—prostate cancer	1.27e-05	0.000113	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—KRAS—prostate cancer	1.26e-05	0.000112	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—FGF2—prostate cancer	1.26e-05	0.000112	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PIK3CD—prostate cancer	1.26e-05	0.000112	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MMP9—prostate cancer	1.25e-05	0.000111	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—CDKN1A—prostate cancer	1.25e-05	0.000111	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—PIK3CA—prostate cancer	1.25e-05	0.000111	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SERPINE1—prostate cancer	1.24e-05	0.000111	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PTEN—prostate cancer	1.24e-05	0.000111	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—NOS3—prostate cancer	1.24e-05	0.000111	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—FGF2—prostate cancer	1.23e-05	0.00011	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—KRAS—prostate cancer	1.23e-05	0.00011	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—NOS3—prostate cancer	1.21e-05	0.000108	CbGpPWpGaD
Bopindolol—HTR1B—Signaling by GPCR—AKT1—prostate cancer	1.21e-05	0.000108	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—JAK2—prostate cancer	1.21e-05	0.000107	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—FGF2—prostate cancer	1.2e-05	0.000107	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—NOS3—prostate cancer	1.19e-05	0.000106	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—EP300—prostate cancer	1.19e-05	0.000106	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—PIK3CA—prostate cancer	1.18e-05	0.000105	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—JAK2—prostate cancer	1.18e-05	0.000105	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MDM2—prostate cancer	1.18e-05	0.000105	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—PIK3CA—prostate cancer	1.18e-05	0.000105	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—ERBB2—prostate cancer	1.16e-05	0.000103	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—PIK3CA—prostate cancer	1.16e-05	0.000103	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—JAK2—prostate cancer	1.15e-05	0.000103	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—SRC—prostate cancer	1.15e-05	0.000103	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MDM2—prostate cancer	1.15e-05	0.000103	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PIK3CB—prostate cancer	1.15e-05	0.000102	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—TP53—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—ERBB2—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—PIK3CA—prostate cancer	1.13e-05	0.000101	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MDM2—prostate cancer	1.13e-05	0.0001	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—VEGFA—prostate cancer	1.12e-05	0.0001	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PIK3CB—prostate cancer	1.12e-05	9.98e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—STAT3—prostate cancer	1.11e-05	9.9e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—ERBB2—prostate cancer	1.11e-05	9.89e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CXCL8—prostate cancer	1.1e-05	9.8e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PIK3CB—prostate cancer	1.1e-05	9.76e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CXCL8—prostate cancer	1.08e-05	9.59e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CDKN1B—prostate cancer	1.08e-05	9.57e-05	CbGpPWpGaD
Bopindolol—ADRB1—GPCR downstream signaling—AKT1—prostate cancer	1.06e-05	9.47e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CASP3—prostate cancer	1.05e-05	9.38e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CXCL8—prostate cancer	1.05e-05	9.38e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL2—prostate cancer	1.05e-05	9.37e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CDKN1B—prostate cancer	1.05e-05	9.36e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—IL6—prostate cancer	1.05e-05	9.32e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—IL6—prostate cancer	1.04e-05	9.28e-05	CbGpPWpGaD
Bopindolol—ADRB2—GPCR downstream signaling—AKT1—prostate cancer	1.04e-05	9.26e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—MYC—prostate cancer	1.03e-05	9.2e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CASP3—prostate cancer	1.03e-05	9.18e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TGFB1—prostate cancer	1.03e-05	9.18e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL2—prostate cancer	1.03e-05	9.16e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CDKN1B—prostate cancer	1.03e-05	9.16e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CCND1—prostate cancer	1.03e-05	9.13e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—IL6—prostate cancer	1.02e-05	9.12e-05	CbGpPWpGaD
Bopindolol—HTR1A—GPCR downstream signaling—AKT1—prostate cancer	1.02e-05	9.06e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CTNNB1—prostate cancer	1.02e-05	9.04e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—EGFR—prostate cancer	1.01e-05	9e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CASP3—prostate cancer	1.01e-05	8.97e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL2—prostate cancer	1.01e-05	8.96e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CCND1—prostate cancer	1e-05	8.93e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—IL6—prostate cancer	1e-05	8.92e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MMP9—prostate cancer	9.96e-06	8.87e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CTNNB1—prostate cancer	9.94e-06	8.85e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—CDKN1A—prostate cancer	9.92e-06	8.83e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PTEN—prostate cancer	9.9e-06	8.81e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CCND1—prostate cancer	9.81e-06	8.74e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MMP9—prostate cancer	9.74e-06	8.67e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CTNNB1—prostate cancer	9.72e-06	8.65e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—CDKN1A—prostate cancer	9.71e-06	8.64e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PTEN—prostate cancer	9.69e-06	8.62e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling by GPCR—AKT1—prostate cancer	9.66e-06	8.6e-05	CbGpPWpGaD
Bopindolol—ADRB3—Signaling Pathways—AKT1—prostate cancer	9.61e-06	8.56e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—KRAS—prostate cancer	9.55e-06	8.5e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MMP9—prostate cancer	9.53e-06	8.48e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—CDKN1A—prostate cancer	9.49e-06	8.45e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PTEN—prostate cancer	9.47e-06	8.43e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling by GPCR—AKT1—prostate cancer	9.45e-06	8.41e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EP300—prostate cancer	9.44e-06	8.41e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling by GPCR—AKT1—prostate cancer	9.24e-06	8.23e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EP300—prostate cancer	9.24e-06	8.22e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—SRC—prostate cancer	9.18e-06	8.17e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EP300—prostate cancer	9.03e-06	8.04e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—SRC—prostate cancer	8.98e-06	8e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—VEGFA—prostate cancer	8.94e-06	7.96e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—STAT3—prostate cancer	8.86e-06	7.88e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—SRC—prostate cancer	8.78e-06	7.82e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—PIK3CA—prostate cancer	8.77e-06	7.81e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—VEGFA—prostate cancer	8.75e-06	7.79e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—STAT3—prostate cancer	8.66e-06	7.71e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—VEGFA—prostate cancer	8.55e-06	7.62e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—TP53—prostate cancer	8.48e-06	7.55e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—STAT3—prostate cancer	8.47e-06	7.54e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—MYC—prostate cancer	8.23e-06	7.33e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TGFB1—prostate cancer	8.21e-06	7.31e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—MYC—prostate cancer	8.05e-06	7.17e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—EGFR—prostate cancer	8.05e-06	7.17e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TGFB1—prostate cancer	8.03e-06	7.15e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—EGFR—prostate cancer	7.87e-06	7.01e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—MYC—prostate cancer	7.87e-06	7.01e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TGFB1—prostate cancer	7.85e-06	6.99e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—IL6—prostate cancer	7.77e-06	6.91e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—EGFR—prostate cancer	7.7e-06	6.85e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—KRAS—prostate cancer	7.6e-06	6.77e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—KRAS—prostate cancer	7.44e-06	6.62e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—KRAS—prostate cancer	7.27e-06	6.47e-05	CbGpPWpGaD
Bopindolol—HTR1B—Signaling Pathways—AKT1—prostate cancer	7.17e-06	6.38e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—PIK3CA—prostate cancer	6.99e-06	6.22e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—PIK3CA—prostate cancer	6.83e-06	6.08e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—TP53—prostate cancer	6.76e-06	6.02e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	6.68e-06	5.95e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—TP53—prostate cancer	6.61e-06	5.88e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—TP53—prostate cancer	6.46e-06	5.75e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—IL6—prostate cancer	6.19e-06	5.51e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—IL6—prostate cancer	6.05e-06	5.39e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—IL6—prostate cancer	5.92e-06	5.27e-05	CbGpPWpGaD
Bopindolol—ADRB1—Signaling Pathways—AKT1—prostate cancer	5.71e-06	5.08e-05	CbGpPWpGaD
Bopindolol—ADRB2—Signaling Pathways—AKT1—prostate cancer	5.58e-06	4.97e-05	CbGpPWpGaD
Bopindolol—HTR1A—Signaling Pathways—AKT1—prostate cancer	5.46e-06	4.86e-05	CbGpPWpGaD
